1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sarcosine in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sarcosine) | Trials (sarcosine) | Recent Studies (post-2010) (sarcosine) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,550 | 69 | 520 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bratton, DL | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sarcosine
Article | Year |
---|---|
Release of platelet activation factor from activated neutrophils. Transglutaminase-dependent enhancement of transbilayer movement across the plasma membrane.
Topics: Cell Membrane; Cystamine; Erythrocyte Membrane; Humans; In Vitro Techniques; Ionomycin; Kinetics; Lipid Bilayers; Membrane Lipids; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Sarcosine; Serum Albumin; Tetradecanoylphorbol Acetate; Time Factors; Transglutaminases | 1993 |